Modified GM3 gangliosides produced by metabolic oligosaccharide engineering

Chad M. Whitman, Fan Yang, Jennifer J. Kohler

Research output: Contribution to journalArticle

14 Citations (Scopus)

Abstract

Metabolic oligosaccharide engineering is powerful approach to altering the structure of cellular sialosides. This method relies on culturing cells with N-acetylmannosamine (ManNAc) analogs that are metabolized to their sialic acid counterparts and added to glycoproteins and glycolipids. Here we employed two cell lines that are deficient in ManNAc biosynthesis and examined their relative abilities to metabolize a panel of ManNAc analogs to sialosides. In addition to measuring global sialoside production, we also examined biosynthesis of the sialic acid-containing glycolipid, GM3. We discovered that the two cell lines differ in their ability to discriminate among the variant forms of ManNAc. Further, our data suggest that modified forms of sialic acid may be preferentially incorporated into certain sialosides and excluded from others. Taken together, our results demonstrate that global analysis of sialoside production can obscure sialoside-specific differences. These findings have implications for downstream applications of metabolic oligosaccharide engineering, including imaging and proteomics.

Original languageEnglish (US)
Pages (from-to)5006-5010
Number of pages5
JournalBioorganic and Medicinal Chemistry Letters
Volume21
Issue number17
DOIs
StatePublished - Sep 1 2011

Fingerprint

G(M3) Ganglioside
Metabolic Engineering
N-Acetylneuraminic Acid
Oligosaccharides
Glycolipids
Biosynthesis
Cells
Cell Line
Cellular Structures
Proteomics
Glycoproteins
Imaging techniques

Keywords

  • Diazirine
  • Ganglioside
  • Metabolic engineering
  • Sialic acid
  • Sialyltransferase

ASJC Scopus subject areas

  • Pharmaceutical Science
  • Drug Discovery
  • Organic Chemistry
  • Molecular Medicine
  • Molecular Biology
  • Clinical Biochemistry
  • Biochemistry

Cite this

Modified GM3 gangliosides produced by metabolic oligosaccharide engineering. / Whitman, Chad M.; Yang, Fan; Kohler, Jennifer J.

In: Bioorganic and Medicinal Chemistry Letters, Vol. 21, No. 17, 01.09.2011, p. 5006-5010.

Research output: Contribution to journalArticle

@article{b7b782b7aef64923b23cf5a071f90123,
title = "Modified GM3 gangliosides produced by metabolic oligosaccharide engineering",
abstract = "Metabolic oligosaccharide engineering is powerful approach to altering the structure of cellular sialosides. This method relies on culturing cells with N-acetylmannosamine (ManNAc) analogs that are metabolized to their sialic acid counterparts and added to glycoproteins and glycolipids. Here we employed two cell lines that are deficient in ManNAc biosynthesis and examined their relative abilities to metabolize a panel of ManNAc analogs to sialosides. In addition to measuring global sialoside production, we also examined biosynthesis of the sialic acid-containing glycolipid, GM3. We discovered that the two cell lines differ in their ability to discriminate among the variant forms of ManNAc. Further, our data suggest that modified forms of sialic acid may be preferentially incorporated into certain sialosides and excluded from others. Taken together, our results demonstrate that global analysis of sialoside production can obscure sialoside-specific differences. These findings have implications for downstream applications of metabolic oligosaccharide engineering, including imaging and proteomics.",
keywords = "Diazirine, Ganglioside, Metabolic engineering, Sialic acid, Sialyltransferase",
author = "Whitman, {Chad M.} and Fan Yang and Kohler, {Jennifer J.}",
year = "2011",
month = "9",
day = "1",
doi = "10.1016/j.bmcl.2011.04.128",
language = "English (US)",
volume = "21",
pages = "5006--5010",
journal = "Bioorganic and Medicinal Chemistry Letters",
issn = "0960-894X",
publisher = "Elsevier Limited",
number = "17",

}

TY - JOUR

T1 - Modified GM3 gangliosides produced by metabolic oligosaccharide engineering

AU - Whitman, Chad M.

AU - Yang, Fan

AU - Kohler, Jennifer J.

PY - 2011/9/1

Y1 - 2011/9/1

N2 - Metabolic oligosaccharide engineering is powerful approach to altering the structure of cellular sialosides. This method relies on culturing cells with N-acetylmannosamine (ManNAc) analogs that are metabolized to their sialic acid counterparts and added to glycoproteins and glycolipids. Here we employed two cell lines that are deficient in ManNAc biosynthesis and examined their relative abilities to metabolize a panel of ManNAc analogs to sialosides. In addition to measuring global sialoside production, we also examined biosynthesis of the sialic acid-containing glycolipid, GM3. We discovered that the two cell lines differ in their ability to discriminate among the variant forms of ManNAc. Further, our data suggest that modified forms of sialic acid may be preferentially incorporated into certain sialosides and excluded from others. Taken together, our results demonstrate that global analysis of sialoside production can obscure sialoside-specific differences. These findings have implications for downstream applications of metabolic oligosaccharide engineering, including imaging and proteomics.

AB - Metabolic oligosaccharide engineering is powerful approach to altering the structure of cellular sialosides. This method relies on culturing cells with N-acetylmannosamine (ManNAc) analogs that are metabolized to their sialic acid counterparts and added to glycoproteins and glycolipids. Here we employed two cell lines that are deficient in ManNAc biosynthesis and examined their relative abilities to metabolize a panel of ManNAc analogs to sialosides. In addition to measuring global sialoside production, we also examined biosynthesis of the sialic acid-containing glycolipid, GM3. We discovered that the two cell lines differ in their ability to discriminate among the variant forms of ManNAc. Further, our data suggest that modified forms of sialic acid may be preferentially incorporated into certain sialosides and excluded from others. Taken together, our results demonstrate that global analysis of sialoside production can obscure sialoside-specific differences. These findings have implications for downstream applications of metabolic oligosaccharide engineering, including imaging and proteomics.

KW - Diazirine

KW - Ganglioside

KW - Metabolic engineering

KW - Sialic acid

KW - Sialyltransferase

UR - http://www.scopus.com/inward/record.url?scp=80051788053&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=80051788053&partnerID=8YFLogxK

U2 - 10.1016/j.bmcl.2011.04.128

DO - 10.1016/j.bmcl.2011.04.128

M3 - Article

C2 - 21620696

AN - SCOPUS:80051788053

VL - 21

SP - 5006

EP - 5010

JO - Bioorganic and Medicinal Chemistry Letters

JF - Bioorganic and Medicinal Chemistry Letters

SN - 0960-894X

IS - 17

ER -